Dis-Chem Pharmacies Full Year 2025 Earnings: Revenues Disappoint

Simply Wall St · 05/31 08:07

Dis-Chem Pharmacies (JSE:DCP) Full Year 2025 Results

Key Financial Results

  • Revenue: R39.2b (up 8.0% from FY 2024).
  • Net income: R1.18b (up 20% from FY 2024).
  • Profit margin: 3.0% (up from 2.7% in FY 2024). The increase in margin was driven by higher revenue.
  • EPS: R1.38 (up from R1.15 in FY 2024).
earnings-and-revenue-growth
JSE:DCP Earnings and Revenue Growth May 31st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Portfolio Valuation calculation on simply wall st

Dis-Chem Pharmacies Revenues Disappoint

Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) was mostly in line with analyst estimates.

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 7.6% growth forecast for the Consumer Retailing industry in South Africa.

Performance of the South African Consumer Retailing industry.

The company's shares are up 3.7% from a week ago.

Risk Analysis

Be aware that Dis-Chem Pharmacies is showing 2 warning signs in our investment analysis and 1 of those makes us a bit uncomfortable...